Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids

American Journal of Surgical Pathology

Volumn 28, Issue 10, 2004, Pages 1371-1378

  Srivastava, Amitabh ^a   Padilla, Osvaldo ^a   Fischer Colbrie, Reiner ^b   Tischler, Arthur S ^a   Dayal, Yogeshwar ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adrenal; Carcinoids; NESP 55; Pancreatic endocrine tumor; Pheochromocytoma

Indexed keywords

CHROMOGRANIN; CHROMOGRANIN A; CHROMOGRANIN B; ILEUM CARCINOID; NEUROENDOCRINE SECRETORY PROTEIN 55; NEURON SPECIFIC ENOLASE; SECRETOGRANIN II; SYNAPTOPHYSIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ANTIGEN RETRIEVAL; ARTICLE; CARCINOID; CELL DIFFERENTIATION; CHROMAFFIN CELL; CONTROLLED STUDY; DISEASE MARKER; ENDOCRINE TUMOR; GASTRIC CARCINOID; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG CARCINOID; MAJOR CLINICAL STUDY; METASTASIS; NEUROENDOCRINE TUMOR; NEUROFIBROMATOSIS; PANCREAS ISLET CELL; PANCREAS TUMOR; PHEOCHROMOCYTOMA; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RECTUM CARCINOID; SIPPLE SYNDROME; TUMOR CELL; VON HIPPEL LINDAU DISEASE;

ADRENAL GLAND NEOPLASMS; CARCINOID TUMOR; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL NEOPLASMS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; ISLETS OF LANGERHANS; LUNG NEOPLASMS; PANCREATIC NEOPLASMS; PHEOCHROMOCYTOMA;

EID: 5044239689     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000135527.96318.20     Document Type: Article

References (40)

1. Aardal S, Helle KB, Elsayed S, et al. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol. 1993;5:405-412.
2. Banks P, Helle K. The release of protein from the stimulated adrenal medulla. Biochem J. 1965;97:40C-41C.
3. Banks P, Helle KB, Mayor D. Evidence for the presence of a chromogranin-like protein in bovine splenic nerve granules. Mol Pharmacol. 1968;5: 210-212.
4. Bauer R, Weiss C, Marksteiner J, et al. The new chromogranin like protein NESP-55 is preferentially localized in adrenaline synthesizing cells of the bovine and rat adrenal medulla. Neurosci Lett. 1999;263:13-16.
5. DeStephano DB, Lloyd RV, Pike AM, et al. Pituitary adenomas: an immunohistochemical study of hormone production and chromogranin localization. Am J Pathol. 1984;116:464-472.
6. Edgren M, Stridsberg M, Kalknar KM, et al. Neuroendocrine markers: chromogranin, pancreastatin, and serotonin in the management of patients with advanced renal cell carcinoma. Anticancer Res. 1996;16:3871-3874.
7. Eriksson B, Arnberg H, Oberg K, et al. Chromogranins-new sensitive markers for neuroendocrine tumors. Acta Oncol. 1989;28:325-329.
8. Fahrenkamp AG, Wibbeke C, Winde G, et al. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumors of the gastrointestinal tract. Virchows Arch. 1995;426:361-367.
9. Feldman SA, Eiden LE. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Endocr Pathol Spring. 2003;14:3-23.
10. Fischer-Colbrie R, Eder S, Lovisetti-Scamihorn P, et al. Neuroendocrine secretory protein 55: a novel marker for the constitutive secretory pathway. Ann NY Acad Sci. 2002;971:317-322.
11. Fischer-Colbrie R, Hagn C, Kilpatrick L, et al. Chromogranin C: a third component of the acidic proteins in chromaffin granules. J Neurochem. 1986;47:318-321.
12. Fischer-Colbrie R, Lassmann H, Hagn C, et al. Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissues. Neuroscience. 1985;16:547-555.
13. Hayward BE, Moran V, Strain L, et al. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally and biallelically derived proteins. Proc Natl Acad Sci USA. 1998;95:15475-15480.
14. Hsiao RJ, Seeger RC, Yu AL, et al. Chromogranin A in children with neuroblastoma serum concentration parallels disease stage and predicts survival. J Clin Invest. 1990;85:1555-1559.
15. Iguchi H, Hara N, Hayashi I, et al. Elevation of a novel pituitary protein (7B2) in the plasma in small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1989;25:1225-1232.
16. Ischia R, Culig Z, Eder U, et al. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostatic tumor cell line. Prostate Suppl. 1998;8:80-87.
17. 1B receptor antagonist activity. J Biol Chem. 1997;17:11657-11662.
18. Jakobsen A-M, Ahlman H, Kolby L, et al. NESP-55, a novel chromogranin like peptide is expressed in endocrine tumors of the pancreas and adrenal medulla but not ileal carcinoids. Br J Cancer. 2003;88:1746-1754.
19. Kimura N, Pilichowska M, Okamoto H, et al. Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod Pathol. 2000;13:140-146.
20. Kirshner N, Sage HJ, Smith WJ, et al. Release of catecholamines and specific protein from adrenal galnds. Science. 1966;154:529-531.
21. Leitner B, Lovisetti-Scamihorn P, Heilmann J, et al. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerves. J Neurochem. 1999; 72:1110-1116.
22. Lloyd RV, Blaivas M, Wilson BS. Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues. Arch Pathol Lab Med. 1985;109:633-635.
23. Lloyd RV, Mervak T, Schmidt K, et al. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol. 1984;8:607-614.
24. Lloyd RV. Immunohistochemical localization of chromogranin in normal and neoplastic endocrine tissues. Pathol Annu. 1987;22:69-90.
25. Lovisetti-Scamihorn P, Fischer-Colbrie R, Leitner B, et al. Relative amounts and molecular forms of NESP-55 in various bovine tissues. Brain Res. 1999;829:99-106.
26. O'Connor DT, Burton D, Deftos LJ. Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues. J Clin Endocrinol Metab. 1983;57:1084-1086.
27. O'Connor DT, Deftos LJ. Secretion of chromogranin A by peptide producing endocrine neoplasms. N Engl J Med. 2003;1986;314:1145-1151.
28. O'Connor DT, Deftos LJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med. 1986;314;1145-1151.
29. Ottiger H-P, Battenberg EF, Tsou A-P, et al. 1B1075: a brain- and pituitary-specific mRNA that encodes a novel chromogranin/secretogranin-like component of intracellular vesicles. J Neurosci. 1990;10:3135-3147.
30. Rosa P, Hille A, Lee RWH, et al. Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. J Cell Biol. 1985;101:1999-2011.
31. Said JW, Vimadalal S, Nash G, et al. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol. 1985;16:236-240.
32. Schmid KW, Fischer-Colbrie R, Hagn C, et al. Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid. Am J Surg Pathol. 1987;11:551-556.
33. Schmid KW, Schroder S, Dockhorn-Dworniczak B, et al. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin I in extra-adrenal paragangliomas. Mod Pathol. 1994;7:347-353.
34. Simon JP, Bader MF, Annis D. Secretion from chromaffin cells is controlled by chromogranin derived peptides. Proc Natl Acad Sci USA. 1988; 85:1712-1716.
35. Stridsberg M, Husebye ES. Chromogranin A and chromogranin B are sensitive circulating markers for pheochromocytomas. Eur J Endocrinol. 1997;136:67-73.
36. Tatemoto K, Efendic S, Mutt V, et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature. 1986;324:476-478.
37. Taupenot L, Harper KL, O'Connor DT. Mechanisms of disease: the chromogranin-secretogranin family. N Engl J Med. 2003;348:1134-1149.
38. Tischler AS, Dayal Y, Balogh K, et al. The distribution of immunoreactive chromogranins, S-100 protein and vasoactive intestinal peptide in compound tumors of the adrenal medulla. Hum Pathol. 1987;18:909-917.
39. Weiler R, Feichtinger H, Schmid KW, et al. Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids. Virchows Arch A Pathol Anal Histopathol. 1987;412:103-109.
40. Weiler R, Fischer-Colbrie R, Schmid KW, et al. Immunological studies on the occurrence and properties of chromogranin A and B and secretogranin II in endocrine tumors. Am J Surg Pathol. 1988;12:877-884.